Literature DB >> 9732383

Characterization of the effects of the partial dopamine agonist terguride on cocaine self-administration in the rat.

L Pulvirenti1, C Balducci, M Piercy, G F Koob.   

Abstract

Dopamine neurotransmission is an important neuropharmacological component of cocaine self-administration in rodents. Terguride is a prototype drug belonging to a recently characterized class of compounds, dopamine partial agonists, which appear to possess a unique pharmacological profile in altering dopamine neurotransmission, where these drugs act as antagonists in conditions of high dopaminergic tone. The aim of the present study was therefore to test the effects of systemic administration of terguride in rats self-administering cocaine intravenously. The different aspects of cocaine self-administration examined after treatment with terguride were (a) the acute reinforcing properties of cocaine in rats exposed to limited-access self-administration of cocaine, (b) a full cocaine dose-effect function, (c) the reinforcing properties of cocaine as measured by a progressive ratio schedule and (d) the ability of terguride to maintain self-administration by itself. Terguride (0.025-0.4 mg/kg i.p.) significantly and dose-dependently reduced the acute reinforcing properties of cocaine as measured by an increase in responding for a single training dose of cocaine and a reduction of the inter-reinforcement interval. In addition, terguride (0.2-0.4 mg/kg) shifted the entire cocaine dose-effect function to the right, thus showing an antagonism of the reinforcing properties of cocaine independent of response rate. Moreover, in rats trained to self-administer cocaine on a progressive ratio schedule, terguride reduced the maximum fixed ratio ("breaking point") for cocaine reinforcement, also suggesting a decrease in the reinforcing properties of cocaine. Finally, in rats trained to self-administer cocaine terguride did not substitute for cocaine, thus indicating that terguride does not maintain intravenous self-administration by itself.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9732383

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.

Authors:  Laura Orio; Sunmee Wee; Amy H Newman; Luigi Pulvirenti; George F Koob
Journal:  Addict Biol       Date:  2010-04-29       Impact factor: 4.280

2.  The partial D2-like dopamine receptor agonist terguride acts as a functional antagonist in states of high and low dopaminergic tone: evidence from preweanling rats.

Authors:  Sanders A McDougall; Rita M Hernandez; Carmela M Reichel; Cristal M Farley
Journal:  Psychopharmacology (Berl)       Date:  2004-11-18       Impact factor: 4.530

3.  Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.

Authors:  Donna M Platt; Joshua S Rodefer; James K Rowlett; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

4.  The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period.

Authors:  Joshua A Lile; William W Stoops; Lon R Hays; Craig R Rush
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

Review 5.  Controversies in translational research: drug self-administration.

Authors:  Margaret Haney; Roger Spealman
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

6.  Phenylpiperazine derivatives with selectivity for dopamine D3 receptors modulate cocaine self-administration in rats.

Authors:  T H C Cheung; B C Nolan; L R Hammerslag; S M Weber; J P Durbin; N A Peartree; R H Mach; R R Luedtke; J L Neisewander
Journal:  Neuropharmacology       Date:  2012-08-31       Impact factor: 5.250

7.  Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease.

Authors:  Jennifer Treweek; Sunmee Wee; George F Koob; Tobin J Dickerson; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

8.  Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice.

Authors:  Gunnar Sørensen; Thomas N Sager; Jørgen H Petersen; Lise T Brennum; Peter Thøgersen; Cecilie Hee Bengtsen; Morgane Thomsen; Gitta Wörtwein; Anders Fink-Jensen; David P D Woldbye
Journal:  Psychopharmacology (Berl)       Date:  2008-05-15       Impact factor: 4.530

Review 9.  Development of pharmacotherapies for drug addiction: a Rosetta stone approach.

Authors:  George F Koob; G Kenneth Lloyd; Barbara J Mason
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

10.  Escalation of methamphetamine self-administration in rats: a dose-effect function.

Authors:  Osamu Kitamura; Sunmee Wee; Sheila E Specio; George F Koob; Luigi Pulvirenti
Journal:  Psychopharmacology (Berl)       Date:  2006-03-17       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.